SCID Model Market 2024

Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033

SCID Model Market by Type (SCID Mice Models, SCID Rat Models, Other), by Application (Immunology Research, Oncology Research, Infectious Disease Research, Transplantation Studies, Regenerative Medicine, Others), by End-User, and by Region – Global Share and Forecast to 2033

Region: Global | Format: Word, PPT, Excel | Report Status: Published

Description

According to the Market Statsville Group (MSG), the Global SCID Model Market size was valued at USD 46.72 million in 2023 and is expected to grow from USD 51.39 million in 2024 to USD 86.11 million by 2033, by exhibiting a CAGR of 5.7% during the forecast period (2024-2033). 

The SCID model market is a market related to the field of medicine and uses animal models, primarily mice, for carrying out biomedical research. The models have been genetically engineered to have inactive immune systems, which makes them very suitable for studying the diseases that occur in human beings, immune responses, and potential treatments. This market is driven by the increasing prevalence of immunodeficiency disorders and a growing demand for personalized medicine. Indeed, biotechnological and genetic engineering advances promote SCID model development and application, which is adopted in turn by the research capabilities of pharmaceutical companies and biotechnological firms. 

North America presently dominates the market based on robust research infrastructure and funding, followed by Europe and the Asia-Pacific market. The market is challenged by strict regulatory policies and high costs associated with establishing and maintaining the models. However, increasing technological improvement being ongoing and growing investment by the key players in the market related to research and development, is projected to boost the growth of the SCID model market in the upcoming years. 


Definition of the SCID Model

SCID (severe combined immunodeficiency) model—genetically engineered animals, usually mice, have no functional immune system and are hence important in studying human diseases, immune responses, and developments in treatment as human cells and tissue can be transferred into the animal without rejection. SCID models are vital in allowing new research to enter the fields of immunology, oncology, and regenerative medicine. 


Global SCID Model Market Dynamics

Drivers: Growing Prevalence of Immunodeficiency Disorders    

A burgeoning prevalence of immunodeficiency disorders has been majorly responsible for the development of the SCID model market. Conditions acquired due to genetic reasons, environmental exposure, or lifestyle changes have increased the disorders. Conditions like HIV/AIDS, primary immunodeficiency diseases, and immunodeficiencies acquired as a result of treatment for cancers only increase the importance of clinical investigations into better treatment management. 

SCID models, along with their compromised immune systems, represent an ideal platform for studying immunodeficiency disorders in full. It presents a unique opportunity in the study of disease mechanisms, testing out new therapeutic approaches, and developing strategies for personalized medicine according to the needs of particular patients. Growing demand for advanced research tools to cope with increased incidences of immunodeficiency disorders represents future driving forces for the SCID model market and indicates that this area of biomedical science is critical enough to continue to encourage investment in continued innovation. With a rise in these diseases, the need for SCID models is expected to increase even more and ensure a surging growth rate for the market. 

Challenges: Regulatory Hurdles and Compliance Requirements 

One of the major challenges in the SCID model market is regulatory hurdles and compliance requirements. The use of genetically engineered animals, such as SCID models, is highly regulated for ethical treatment and scientific validity for the same. Accordingly, researchers and companies have to deal with complex approval procedures at institutional review boards, government agencies, and ethical committees. The list goes beyond those mandatory under international consensus documents and legislation, notably the Animal Welfare Act in the United States and the European Directive on the protection of animals used for scientific purposes. The acts contribute to negative administrative workload and expenses imposed by the enforcement thereof; this was intended to provide humane treatment of the creatures and reduce unnecessary suffering; however, it slows down the research speed and increases the operational costs. The regulatory landscapes for these areas are so extensive that they require a lot of expertise and resources for navigation, so this can greatly limit the capability of smaller entities to play in the SCID model market and make overall progress in research and development. 


Scope of the Global SCID Model Market 

The study categorizes the SCID Model market based on application, type, and end-users at the regional and global levels.

By Type Outlook (Sales, USD Million, 2019-2033)

  • SCID Mice Models
  • SCID Rat Models
  • Other 

By Application Outlook (Sales, USD Million, 2019-2033)

  • Immunology Research
  • Oncology Research
  • Infectious Disease Research
  • Transplantation Studies
  • Regenerative Medicine
  • Others

By End-Users Outlook (Sales, USD Million, 2019-2033)

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations (CROs)
  • Others

By Region Outlook (Sales, USD Million, 2019-2033)

  • North America 
    • US
    • Canada
    • Mexico
  • Europe 
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific 
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

SCID mice models segment accounts for the largest market share by type

Based on the type, the market is divided into SCID mouse models, SCID Rat Models, and others. The infotainment segment accounted for the largest market share in the global SCID Model market. The segment for SCID mice models is likely to dominate the SCID model market since mice have been comprehensively used in biomedical research due to their genetic similarity with humans and their short reproductive cycles, as well as established techniques of genetic manipulation. SCID mice are irreplaceable in studying human immune responses, oncology, and infectious diseases because they can be engrafted with human cells and tissues that have the potential to be generated into humanized models. Their applicability is further enhanced with the availability of different strains of SCID mice engineered to suit specific research purposes. Some volume of research and data for SCID mice are already available, making comparative studies easier and speeding up new research initiatives. Cost-effectiveness and ease of handling SCID mice compared to other animal models for research purposes also add to their wide adoption and consequently strengthen their leading position in the market. 

North America accounted for the largest market share by Region.

Based on the regions, the global market of SCID Model has been segmented across North America, Europe, the Middle East & Africa, South America, and Asia-Pacific. North America dominates the SCID model market as a region, as it is home to most of the world's robust research infrastructure, substantial funding, and a concentration of leading biotechnology and pharmaceutical companies. More specifically, the United States leads the world's biomedical research and development race, which is funded mainly by governmental agencies and private entities with huge investments. This financial backing allows for innovation and the development of SCID models in advanced places. Besides, many top-rated research institutions and universities perform cutting-edge studies based in North America and cooperate. 

The regulatory framework is very well established, therefore tight in the American region, but gives clear guidelines to work by for compliance and ethics in research. Strong industry networking, experienced human resources, and solid technological development further cement the leadership of North America in the SCID model market, enabling it to draw in global talent and resources for advancing immunological and medical research. 


Competitive Landscape: Global SCID Model Market 

Key competing participants in the global SCID model market engage with strategies focused on innovation to develop advanced model offerings and work towards entering collaborations to extend research capabilities. Key players augmenting innovation, along with rising investments in biomedical research and personalized medicine, are driving the SCID model market globally. Key industries operating within the overall SCID model market include leading biotechnology and pharmaceutical companies, research institutions, and universities.

Major players in the global SCID Model market are: 


Recent Developments 

  • In June 2024, Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics with a focus on oncology and immunology, resubmitted the Biologics License Application (BLA) for its product called batoclimab (HBM9161) with the National Medical Products Administration (NMPA) of China.
  • In October 2021, The Jackson Laboratory, a nonprofit biomedical research institute and provider of lab animal resources, purchased as a wholly owned subsidiary the RMS division of Charles River Laboratories Japan.

Frequently Asked Questions

  • Key Issues Addressed
  • What is the market size and growth rate for different segmentations at a global, regional, & country level?
  • What is the customer buying behavior, key takeaways, and Porter's 5 forces of the market?
  • What are the key opportunities and trends for manufacturers involved in the supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of in the market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Who are the leading companies operating in the market? Also, who are the prominent startups that disrupt the market in coming years?
  • PUBLISHED ON: MARCH, 2024
  • BASE YEAR: 2023
  • FORECAST PERIOD: 2024-2033
  • STUDY PERIOD: 2019 - 2033
  • COMPANIES COVERED: 15
  • COUNTRIES COVERED: 24
  • NO OF PAGES: 288

Want to Review Complete Market Research Report

 
save 20%
$2450 $1950
 
save 25%
$4450 $3338
 
save 30%
$5850 $4095
 
save 35%
$8150 $5298

Budget constraints? Get in touch with us for special pricing

Request for Special Pricing

Customize this Report

  • Buy specific region or segment sections of this report
  • Buy specific region/country level reports
  • Request for Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • Companies Profiles based on Target Requirement
  • Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
  • Why Choose Market Statsville Group?
  • CXO’s Perspective
  • Real-Time Market AttractivenessIndex
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Robust Research Methodology
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept